The potential interaction between acetylsalicylic acid and angiotensin-converting enzyme inhibitors in patients with heart failure has received considerable attention lately. Opposing effects on prostaglandin synthesis and metabolism form the theoretical basis of an interaction. A review of the available literature revealed conflicting data from animal studies, human pharmacological studies, an...